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Summary
 
In the thymus, T cells are selected according to their T cell receptor (TCR) specificity. After
positive selection, mature cells are exported from primary lymphoid organs to seed the second-
ary lymphoid tissue. An important question is whether survival of mature T cells is an intrinsic
property or requires continuous survival signals, i.e., engagement of the TCR by major histo-
compatibility complex (MHC) molecules in the periphery, perhaps in a similar way as occur-
ring during thymic positive selection. To address this issue we used recombination-activating
gene (Rag)-deficient H-2
 
b
 
 mice expressing a transgenic TCR restricted by I-E
 
d
 
 class II MHC
molecules. After engraftment with Rag
 
2
 
/
 
2
 
 H-2
 
d
 
 fetal thymi, CD4
 
1
 
8
 
2
 
 peripheral T cells
emerged. These cells were isolated and transferred into immunodeficient hosts of H-2
 
b
 
 or H-2
 
d
 
haplotype, some of the latter being common cytokine receptor 
 
g 
 
chain deficient
 
 
 
to exclude re-
jection of H-2
 
b
 
 donor cells by host natural killer cells. Our results show that in the absence, but
not in the presence, of selecting MHC molecules, peripheral mature T cells are short lived and
disappear within 7 wk, indicating that continuous contact of the TCR with selecting MHC
molecules is required for survival of T cells.
 
P
 
ositive selection of T cells in the thymus requires the
interaction of the TCR on immature thymocytes with
self-MHC molecules expressed on thymic epithelial cells
(1–3). This process is dependent on the continual interac-
tion of TCRs to MHC molecules since the transfer of thy-
mocytes exhibiting only the first signs of positive selection
(i.e., TCR upregulation and CD69 expression) into hosts
lacking appropriate MHC molecule expression results in
the loss of the transferred cells (4, 5). The presence of cer-
tain intermediate stages of T cell development in different
gene-deficient mice also indicated that T cells were se-
lected by a multistep process (6–8). Nevertheless, T cells do
acquire functional maturity within the thymus since they
can be stimulated to divide (9–11), as was found for recent
thymic emigrants (12).
After the export to secondary lymphoid organs, some
naive T cells do not divide but are long lived with an inter-
mitotic lifespan of the order of 8 wk in euthymic mice, and
much longer in athymic mice (13, 14). These experiments
were performed in mice expressing the same MHC mole-
cules in peripheral lymphoid tissue that induced positive se-
lection in the thymus. Recently, some evidence was pre-
sented that MHC molecules in the peripheral lymphoid
organs may have a role in sustaining long-term survival of
mature T cells (15). We have addressed the same question
in a different experimental system and, even though we agree
that MHC molecules do support the survival of mature T
cells, we have obtained results that differ from those obtained
in the previous report (15). In our experiments, we have
grafted recombination activating gene (Rag)
 
1
 
-deficient mice
of H-2
 
b
 
 haplotype that express a transgenic I-E
 
d
 
-restricted
TCR with thymi from fetal H-2
 
d
 
 Rag
 
2
 
/
 
2
 
 mice. This al-
lowed the positive selection of CD4
 
1
 
8
 
2
 
 T cells expressing
the transgenic TCR. These cells were transferred into im-
munodeficient hosts of either H-2
 
b
 
 or H-2
 
d
 
 haplotype,
some of the latter being deficient in expression of the com-
mon cytokine receptor 
 
g
 
 chain (IL-2R
 
g
 
2
 
/
 
2
 
) and therefore de-
void of NK cells (16, 17). The results show that H-2
 
d
 
-restrict-
ing MHC molecules are required for survival of the transferred
T cells in secondary lymphoid tissue.
 
Materials and Methods
 
Mice.
 
BALB/c and BALB/c nu/nu mice were from IFFA-
Credo (Orléans, France). BLACK nu/nu mice were from Bom-
holtgart (Ry, Denmark) and screened for H-2
 
b
 
 homozygosity.
Rag-2– (18) and Rag-1– (19) deficient mice were H-2
 
b
 
 homozy-
 
1
 
Abbreviations used in this paper:
 
 dGuo, 2
 
9
 
-deoxyguanosine; Rag, recombi-
nation activating gene; sIg, surface Ig; HSA, heat stable antigen.
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gous. Hemagglutinin-specific TCR transgenic mice (ABII
 
 
 
TCR)
on Rag-2
 
2
 
/
 
2
 
 background have been described (8, 20). H-2
 
d
 
Rag-2
 
2
 
/
 
2
 
 mice were obtained from Drs. Antonius Rolink and
Shunichi Takeda (Basel Institute for Immunology, Basel, Swit-
zerland; reference 15). These mice were crossed with IL-2R
 
g
 
2
 
/
 
2
 
mice to obtain H-2
 
d
 
 Rag-2
 
2
 
/
 
2
 
 IL-2R
 
g
 
2
 
/
 
2
 
 mice. All breeding
was done in the animal colonies at the Basel Institute for Immu-
nology (Basel, Switzerland) and at the Netherlands Cancer Insti-
tute (Amsterdam, The Netherlands).
 
B Cell Depletion, Cell Sorting, and FACS Analysis.
 
Single cell
suspensions of thymus, lymph nodes, and/or spleen (RBCs lysed
or removed by Ficoll density gradient centrifugation) were pre-
pared in PBS with 2% FCS. Where applicable, surface immuno-
globulin-positive (sIg
 
1
 
) cells were depleted using Dynabeads (Mi-
lan, Switzerland).
6.5 (anti-ABII-TCR; reference 8) and MKD6 (anti-I-A
 
b
 
d
 
; ref-
erence 21) mAbs were labeled with FLUOS (Boehringer Mann-
heim, Mannheim, Germany). Heat stable antigen (HSA)-specific
mAbs M1/69 (22) were biotinylated. FITC-labeled 104.2.1 mAbs
(anti-Ly-5
 
b
 
; reference 23) were a gift of Dr. Hans-Reimer Rode-
wald (Basel Institute for Immunology, Basel, Switzerland). Anti-
CD4-PE, anti-CD8-Red613 (GIBCO BRL, Gaithersburg, MD),
and streptavidin-allophycocyanin (Molecular Probes Inc., Eu-
gene, OR) conjugates were obtained commercially.
Cells were stained with mAbs at optimal dilution as deter-
mined before. Three and four-color flow cytometry was per-
formed on FACStar
 
1
 
Ò
 
 or FACS-Vantage
 
Ò
 
 (Becton Dickinson,
Mountain View, CA) instruments.
Data (up to 5 
 
3
 
 10
 
5
 
 events) were stored in list mode and ana-
lyzed with Lysys II or CellQuest software (Becton Dickinson).
Dead cells were excluded using forward- and side-scatter parame-
ters. Data are presented as dot plots with numbers in quadrants or
regions indicating the proportion of cells within that area. Data
from lymph nodes or spleen gave similar results whenever ana-
lyzed.
The recovery of transferred cells was calculated from the abso-
lute number of cells recovered from spleen plus two times the
number of cells recovered from lymph nodes each multiplied by
 
the percentage of cells within the region of interest as determined
by FACS
 
Ò
 
 analysis. In case of staining before and after depletion
of sIg
 
1
 
 cells, the average of both determinations, taking into ac-
count sIg
 
1
 
 cell depletion, was used for calculation. Note that
from the experience of others, the recovery of lymphocytes im-
mediately after transfer is estimated to be 
 
z
 
20% after intravenous
transfer (14, 24).
 
Lymphocyte Proliferation Assay.
 
Cell sorter purified responder
cells were cultured with 5 
 
3 
 
10
 
5
 
 X-irradiated (2,200 rad) stimula-
tor cells in 200 
 
m
 
l Iscove’s modified Dulbecco’s medium supple-
mented with FCS (10%), 
 
b
 
-mercaptoethanol (5 
 
3
 
 10
 
2
 
5
 
 M), pen-
icillin (100 IU/ml), and streptomycin (100 mg/ml). To some
cultures, peptide 107-119 of influenza hemagglutinin (SVSS-
FERFEIFPK) was added at a final concentration of 5 
 
m
 
M. Cul-
tures were kept in a water-saturated atmosphere of 6% CO
 
2
 
 in air
at 37
 
8
 
C. After 48–60 h, 1 
 
m
 
Ci [
 
3
 
H]thymidine (Amersham Corp.,
Arlington Heights, IL) was added and cells were cultured for a
further 12–24 h when they were harvested. Incorporated radioac-
tivity was measured by standard liquid scintillation counting.
 
Fetal Thymus Transplantation and Adoptive Transfers.
 
Fetal H-2
 
d
 
Rag-2
 
2
 
/
 
2
 
 thymi were isolated at days 14–16 of gestation (plug
day 
 
5
 
 day 0). For some experiments (Fig. 1), thymus lobes were
isolated from BALB/c mice and cultured 5 d in medium contain-
ing 1.35 mM 2
 
9
 
-deoxyguanosine (dGuo; Sigma Chemical Co.,
St. Louis, MO). 1–2 lobes were transplanted under the kidney
capsule of H-2
 
b
 
 or H-2
 
b/d
 
 ABII TCR Rag-2
 
2
 
/
 
2
 
 mice. 6–16 wk
later, cells were isolated from lymph nodes and spleen, stained
with CD4, CD8, and I-A
 
b
 
d
 
-specific mAbs, and cell sorter puri-
fied. CD4
 
1
 
8
 
2
 
 I-A
 
b
 
d
 
2
 
 and CD4
 
2
 
8
 
low/
 
1
 
I-A
 
b
 
d
 
2
 
 cells were injected
intravenously into various 4–6-wk-old recipient mice.
 
Results
 
H-2
 
d
 
-restricted CD4
 
1
 
8
 
2
 
 T Cells in Thymus Grafted ABII TCR
Rag
 
2
 
/
 
2
 
 H-2
 
b
 
 Mice.
 
In our studies, we used ABII TCR
transgenic mice that express a transgenic TCR specific for
peptide 111-119 of influenza hemagglutinin presented by
Figure 1. Thymic develop-
ment of CD4182 T cells in H-2d
fetal thymus–grafted H-2b ABII
TCR Rag2/2 mice. H-2b ABII
TCR Rag2/2 mice were trans-
planted with BALB/c fetal thymi
that had been treated with dGuo.
Several weeks after transplanta-
tion, thymocytes from grafted
and host thymi were recovered
and analyzed by four-color flow
cytometry including the ABII
TCR–specific mAb 6.5. Similar
data were obtained when graft-
ing H-2d Rag2/2 thymi that,
however, grew much more ex-
tensively (average of 3.5 3 107
thymocytes). 
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I-E
 
d
 
 class II MHC molecules. These mice were crossed
onto the Rag
 
2
 
/
 
2
 
 background to exclude the interference
of TCRs with unknown specificity due to lack of allelic
exclusion of the TCR-
 
a
 
 locus (25, 26). To obtain T cells
that are selected in the thymus but not able to encounter
the selecting MHC molecules in peripheral lymphoid tis-
sue, we transplanted H-2
 
b ABII TCR Rag2/2 mice with
fetal thymi of H-2d haplotype that had been depleted of
hematopoietic cells or were from Rag2/2 background. (It
is possible that some donor thymus-derived I-Ed–express-
ing cells emigrate from the graft. This will be addressed be-
low.) Under such conditions, the thymus graft is seeded by
T cell precursors of the host such that mature CD4182 T
cells with the transgenic TCR develop in the grafted H-2d,
but not the host H-2b thymus (Fig. 1). Subsequently,
CD4182 T cells from the grafted thymus are exported to
the periphery (Fig. 2). Such CD4182 peripheral T cells are
not present in H-2b ABII TCR Rag2/2 mice, since cells
with the I-Ed-restricted ABII TCR cannot develop in a H-2b
thymus (8). There are also CD428low T cells in these mice
that will be discussed below.
To confirm that the CD4182 T cells in grafted mice
were functionally mature, cells from such mice as well as
from H-2d ABII TCR Rag2/2 mice were isolated and
stimulated with antigen presented by H-2d APCs. As
shown in Table 1, both populations of cells gave prolifera-
tive responses that were in the same order of magnitude,
indicating that they had acquired functional competence.
There was, however, a clear difference in the absolute
number of CD4182 T cells in the thymus-grafted H-2b
ABII TCR Rag2/2 mice and the H-2d ABII TCR Rag2/2
mice in that the former contained far fewer cells than the
latter (2.9 3 106; n 5 3); and ranging between 107 to 108,
respectively). This difference could be due to the fact that
fewer CD4182 T cells are produced/exported from the
grafted thymus and/or the fact that the lack of I-Ed class II
MHC molecules in the peripheral lymphoid organs of
grafted H-2b ABII TCR Rag2/2 mice resulted in a shorter
life span of these cells. Further, the few CD4182 T cells
might be continuously renewed and/or depend on few
I-Ed–expressing cells originating from the fetal thymus
graft. To address the issue of whether peripheral expression
of MHC molecules the CD4182 T cells were selected on
in the thymus was required for their peripheral survival, we
performed transfer experiments into immunodeficient hosts
expressing different MHC molecules.
CD4182 Peripheral T Cells from H-2d Thymus-Grafted H-2b
ABII TCR Rag2/2 Mice Disappear in H-2b but Not in H-2d Adoptive
Hosts. We have shown previously that CD428low cells
with the transgenic ABII TCR are an abundant subset in
peripheral lymphoid organs of H-2b ABII TCR Rag2/2
mice and therefore do not need I-Ed MHC molecules for
selection and survival (8). This population most likely re-
sults from the unusual early expression of the a/b-TCR in
TCR transgenic mice leading to the formation of g/d lin-
eage T cells that express the transgenic a/b-TCR on the
cell surface as discussed by Bruno et al. (27). Here, this sub-
set serves as a convenient internal control to determine en-
graftment.
Cell sorter–purified CD4182 and CD428low cells from
thymus-grafted H-2b ABII TCR Rag2/2 mice were trans-
ferred into either H-2b or H-2d immunodeficient recipient
mice. As shown in Fig. 3, no 6.51CD4182 cells could be
detected in either H-2b nu/nu or H-2d nu/nu recipient
mice 7 wk after transfer, whereas 6.51CD428low cells were
found in the H-2b but not H-2d recipients. (Similar results
were obtained after transfer into H-2b Rag2/2 or H-2d
Rag2/2 recipient mice, data not shown.) In terms of en-
graftment, this result would be compatible with the notion
that the transferred cells expressing H-2b MHC molecules
only, could engraft in H-2b hosts, but not in H-2d hosts be-
cause of rejection by host NK cells (28–30). To circumvent
this problem, a similar transfer of cells from thymus-grafted
H-2b ABII TCR Rag2/2 mice was performed into H-2b
Rag2/2 and H-2d Rag2/2 IL-2Rg2/2 mice, devoid of NK
Figure 2. CD4182 lymphocytes are present in H-2b ABII TCR Rag2/2
mice grafted with an H-2d fetal thymus. Lymphocytes were recovered
from H-2d ABII TCR Rag2/2 and H-2b ABII TCR Rag2/2 mice that
had previously been transplanted with fetal thymus lobes from H-2d
Rag2/2 mice. Cells were analyzed by four-color flow cytometry as
shown.
Table 1. Proliferation of CD4182 ABII TCR Lymphocytes 
Positively Selected in Endogenous or Transplanted H-2d Rag2/2 Thymi
Stimulators (2,200 rad)
CD4182 responders of
BALB/c
nu/nu
BALB/c
nu/nu 1 peptide
ABII RAG-22/2 H-2d 600 15,000
ABII RAG-22/2H-2b ¬ 
FThy RAG-22/2 H-2d 260 23,000
None 160 170
CD4182 lymphocytes were cell sorter purified from H-2d ABII TCR
Rag2/2 and H-2b ABII TCR Rag2/2 mice that had previously been
transplanted with an H-2d Rag2/2 fetal thymus. 5 3 104 responder cells
were cultured with irradiated BALB/c nu/nu stimulators. To some cul-
tures, peptide had been added as source of antigen.1272 Peripheral T Cell Survival and TCR–MHC Interaction
cells (16, 17). As shown in Fig. 4, 6.51CD4182 cells sur-
vived only in H-2d recipients, whereas 6.51CD428low cells
survived both in H-2b and H-2d recipients when analyzed 7
wk after transfer. Taken together, these results show that in
H-2b recipients, NK cells do not reject the transferred cells
as 6.51CD428low cells survive, but 6.51CD4182 cells van-
ish due to the lack of H-2d MHC molecules. In contrast,
6.51CD4182 cells survive long term in the presence of
H-2d MHC molecules once not rejected by NK cells.
6.51CD428low cells survived then as well.
In other experiments, we have followed the fate of
CD4182 and CD428low cells from thymus-grafted H-2b/d
ABII TCR Rag2/2 mice upon transfer into either H-2b or
H-2d immunodeficient recipient mice. (The H-2b/d ABII
TCR Rag2/2 mice themselves cannot select the ABII
TCR in the thymus due to preferential pairing of Ea with
Ebb chains; references 8, 31, 32.) 3 d after transfer, both
populations were present in H-2b nu/nu and H-2d nu/nu
recipients. 7 wk later, both subsets were present in H-2d
nu/nu recipients but could no longer be found in H-2b
nu/nu recipients (data not shown, made available to re-
viewers). This might indicate that the shared class I MHC
molecule expression between H-2b/d hybrid donor and ho-
mozygous host protected the donor cells from NK cell–
mediated lysis in H-2d homozygous hosts, but that the re-
duced class I H-2b MHC molecule expression of H-2b/d
hybrid cells was not sufficient to circumvent NK cell–medi-
ated  lysis in H-2b homozygous hosts. Such differences
might become evident only upon transfer of relatively small
numbers of cells as performed here. An inverse correlation
between the level of class I expression and NK cell lysis has
indeed been observed (33), and NK cell–mediated lysis of
hybrid cells did not always occur to the same extent in each
of the parental strains (34). Further, H-2b cells expressing
transgene-encoded Dd MHC class I molecules were re-
jected by NK cells in otherwise syngenic H-2b hosts (35).
Discussion
Our data show that appropriate MHC molecules are re-
quired to support the survival of mature a/b T cells in pe-
ripheral lymphoid tissue; a conclusion in line with previ-
ously published experiments (15). In the latter study,
however, polyclonal CD4182 T cells in thymus-grafted Rag
class II MHC double deficient mice appeared to survive
much longer since significant numbers of cells could still be
found 16 wk after export from the thymus ceased. This
may be due to the fact that in these experiments, CD4182
T cells with class I MHC–restricted TCRs (36–38) could
interact with class I MHC molecules expressed in the pe-
ripheral lymphoid tissue or due to the fact that some class II
MHC–positive cells had migrated from the transplanted
thymus into the periphery. In both of these cases, T cells
could have been stimulated by antigen. The high propor-
tion of proliferating CD4182 T cells at various points in
time after thymus transfer could indicate that this was in-
deed the case, and some CD4182 T cells might have rather
disappeared because of exhaustion (39, 40). These possibil-
Figure 3. CD4182 lymphocytes from H-2d thymus-grafted H-2b ABII TCR Rag2/2 mice disappear in H-2b adoptive hosts. 7.5 3 105 CD4182 and
5 3 105 CD428low lymphocytes from H-2d Rag2/2 fetal thymus–transplanted H-2b ABII TCR Rag2/2 mice were adoptively transferred into H-2b and
H-2d nu/nu mice. 7 wk later, cells from lymph nodes and spleen (RBCs lysed) were isolated, depleted of sIg1 cells, and analyzed by four-color flow cy-
tometry. Data from lymph nodes and spleen gave similar results. Calculated numbers of 6.51HSA2 cells were 5,600, 6,500, and 1,800 for CD4182 and
1,800, 463,600, and 400 for CD428low cells in unmanipulated H-2b (one mouse), injected H-2b (average of two mice), and injected H-2d (average of two
mice) nu/nu mice, respectively. (Note that numbers also contain the calculated background values of mice not injected.) Another experiment and two
experiments using H-2b Rag2/2 and H-2d Rag2/2 recipients gave similar results.1273 Kirberg et al.
ities were excluded in our experiments; the CD4182 T
cells were of known antigen specificity and MHC restric-
tion. Any potential class II MHC molecule–expressing cells
originating from the thymus graft were removed by cell
sorting before transfer into adoptive recipients.
In line with our previous observations, we noticed ex-
pansion of CD4182 ABII TCR-expressing cells in H-2d
mice (reference 41 and this report). Currently, it is not
clear whether T cell survival in the absence (13, 14) or the
presence (41) of proliferation (or both possibilities) reflects
the normal physiologic situation. Interestingly, normal
mice that had been thymectomized have some cells of na-
ive phenotype that label with BrdU (42).
Irrespective of the MHC environment, CD428low cells
that are not dependent on positive selection in the thymus,
did expand after transfer. Presently, the biology of these
cells is not well understood and it has been speculated that
these cells represent g/d lineage T cells expressing the
transgenic  a/b-TCR (27).
While it becomes established that T cells require the in-
teraction of their TCRs with selecting MHC molecules for
survival in the peripheral lymphoid tissue, the mechanism
behind this requirement is unknown. In the thymus, im-
mature CD4182 cells express low levels of the cell death–
repressing bcl-2 protein. They have a half life of 3 d (43)
unless their TCR binds with sufficient affinity to self-
MHC molecules resulting in maturation that is accompa-
nied by bcl-2 upregulation (44–47). One might then spec-
ulate that the level of bcl-2 expression and, hence, survival
is (indirectly) regulated by TCR ligation with selecting MHC
molecules in the absence of antigen. In that respect, periph-
eral survival could be similar to thymic positive selection. The
data reported on T cells from bcl-2–deficient mice are com-
patible with such a hypothesis (48–51). We have investigated
bcl-2 expression by intracellular staining of CD4182 cells
from thymus-grafted H-2b ABII TCR Rag2/2 and H-2d
ABII TCR Rag2/2 mice. However, the differences we ob-
served were far less dramatic than during thymic positive
selection (mean fluorescence reduced to 74 compared to 98
in controls, whereas in the thymus, a threefold difference was
detectable: 44 versus 120 in an independent experiment).
This could be due to the fact that cells with low bcl-2 expres-
sion are rapidly dying and eliminated and escape detection.
Further, it will be of interest to determine whether TCR
contact with selecting MHC molecules on any type of cell
is sufficient for T cell survival or whether the selecting
MHC molecules have to be encountered on a specific cell
type. The latter would be analogous to the requirement of
TCR–MHC molecule interaction on thymic epithelial
cells for thymic positive selection (3). Interestingly, RelB-defi-
cient mice that lack dendritic cells have an increased pro-
portion of activated T cells, whereas absolute numbers of T
cells are reduced (52, 53). The former might be due to lim-
ited self-censorship in the thymus followed by peripheral
activation by self-antigens the T cells were not tolerized for
in the thymus (52–55). The latter, however, could indicate
that (naive) peripheral T cell survival requires TCR inter-
action with selecting MHC molecules on dendritic cells.
The data of DeKoning et al. on transfer of naive TCR
transgenic T cells into RelB2/2 mice support this theory (53).
Figure 4. CD4182 lymphocytes from H-2d thymus-grafted H-2b ABII TCR Rag2/2 mice survive in H-2d NK cell–deficient adoptive hosts. 105
CD4182 and 105 CD428low lymphocytes from H-2d Rag2/2 fetal thymus–transplanted H-2b ABII TCR Rag2/2 mice were adoptively transferred into
H-2b Rag2/2 and H-2d Rag2/2 IL-2Rg2/2 mice. 7 wk after transfer, cells from lymph nodes and spleen were analyzed as in Fig. 3. Calculated numbers
of 6.51HSA2 cells were 900, 13,500, 5,900, and 3 3 106 for CD4182 and 600, 6,100, 7.6 3 105, and 1.5 3 106 for CD428low cells in unmanipulated
H-2d Rag2/2 IL-2Rg2/2, unmanipulated H-2b Rag2/2 (not shown), injected H-2b Rag2/2, and injected H-2d Rag2/2 IL-2Rg2/2 mice, respectively.
Expansion in Rag-deficient H-2d mice was consistent with previous data (41). We also performed this type of experiment with two thymectomized H-2d
Rag2/2 IL-2Rg2/2 mice and obtained similar results.1274 Peripheral T Cell Survival and TCR–MHC Interaction
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